Delivery Order SPE2DB22D3016-SPE2DB24FAJK9
Award Date 1/16/24
Potential Completion Date 1/17/24
Potential Value $35K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a $61,256 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply MENQUADFI VIAL 0.5ML pharmaceutical products. This delivery order was placed under Amerisourcebergen's existing indefinite delivery contract with DLA Troop Support Medical to provide pharmaceuticals and medical supplies for military treatment programs and facilities. The contract has a completion date of...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, for the provision of a pharmaceutical product, MENQUADFI VIAL 0.5ML. The contract has a potential value of $2,457.26 and a completion date of January 19, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor on this award, which is not...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply MENQUADFI VIAL 0.5ML pharmaceutical products. The $35,124.00 contract has a performance period ending on January 11, 2024. Amerisourcebergen Drug Corp, a for-profit organization, provides pharmaceutical products and services to U.S. government agencies, primarily the Department of Defense. This delivery order was not...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract, valued at $2,809.92, is for the delivery of MENQUADFI VIAL 0.5ML pharmaceutical products to Conshohocken, Pennsylvania. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp serves as the prime contractor and has previously held other indefinite...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply MENQUADFI VIAL 0.5ML pharmaceutical products. The contract has a potential value of $5,654.52 and a performance period through February 23, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and holds an indefinite delivery contract (IDC) with DLA valued at up to...
- This is a $4,934.45 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The award is for the supply of MENQUADFI VIAL 0.5ML pharmaceutical products, with a performance period ending on January 25, 2024. This delivery order is part of Amerisourcebergen Drug Corp's prime contract with DLA to provide...
- This is a firm fixed price delivery order worth $108,374.22, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical sourcing and distribution company. The order is for the supply of MENQUADFI VIAL 0.5ML, a pharmaceutical product. No set-aside designation was used. AmerisourceBergen Drug Corp is a prime contractor that has received numerous federal contracts from DLA Troop Support Medical to provide...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,435.58 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide MENQUADFI VIAL 0.5ML pharmaceuticals. The order is set to be completed by December 7, 2023 and was awarded on December 6, 2023. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor that has received numerous federal contract awards from DLA to supply pharmaceuticals, medical...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The $1,756.20 order is for the supply of MENQUADFI VIAL 0.5ML, a pharmaceutical product. The award does not have a set-aside designation and the place of performance is Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp is an experienced...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4563276138 MENQUADFI VIAL 0.5ML. The potential value of the contract is $1,404.96. This delivery order was issued under Amerisourcebergen's existing contract to provide pharmaceuticals, medical supplies, and related distribution services to DLA Troop Support Medical facilities. Amerisourcebergen has a history of supporting DLA...